News About: Pharm. Industry
Korean national named first Asian clinical research coordinator
Novartis Korea announced the appointment of Kang Ja-hoon, currently assistant manager of the company's Clinical and Medical Division, to the position of Asian clinical research coordinator in International Clinical Re...
Sharp bipolar phenomenon in pharmaceutical economy.
Although overall business in the pharmaceutical industries showed an ongoing rise, there appeared with a severe disparity among the companies.
The business achievement up to the 3rd quarter this year after 2003 rec...
Pfizer Korea's counter attacks for Norvasc defence.
Pfizer Korea began to counter attack against the Norvasc rival products by quoting their survey data describing a superior product position to other rivals in terms of its efficacy and safety proven for a long time.
...
KOSDAQ-listed pharmaceutical firms' sales rise 12.4%
The 15 KOSDAQ-listed pharmaceutical manufacturing firms marketed combined sales of 347.2 billion won in the first nine months of this year, an increase of 12.4 percent due to brisk sales of generic or new drug...
KSE-listed pharmaceutical firms showing strong 3-quarter results
KSE (Korea Stock Exchange)-listed pharmaceutical firms in the first nine months of this year continued to post robust sales of 2.4 trillion won, up 14.5 percent compared with 2.1 trillion won from a year earlier, acco...
Target marketing on OTC drugs at pharmacy.
Pharmacists are trying to increase OTC drugs sales by so called a target marketing strategy in an attempt to overcome the recent economy recession.
The target marketing focused on a certain class of consumers or sp...
Hanmi Pharm wins US patent for amlodipine camsylate
Hanmi Pharm said it has acquired an U.S. patent for the manufacturing process of amlodipine camsylate with better combination of properties in terms of photo stability and purity, soon after the obtainment of the Kore...
Two foreign vaccine firms faces penalty for false ads
The Korea Food and Drug Administration said on November 11 that it is considering taking administrative measures to deal with two foreign-invested pharmaceutical firms, GlaxoSmithKline (GSK) and Sanofi-Aventis Korea, ...
Novartis saying no more exclusive distributions.
In the brief meeting with 15 associated drug wholesalers out of the total 50 at 4 p.m. on Nov. 11 at Hilton hotel, Novartis made it clear not to keep an exclusive distribution policy with any wholesalers in the future...
Korea Green Cross poised to break one trillion won barrier in 2010 sales
As a total healthcare service provider, Korea Green Cross Corporation unveiled on November 10 its plan to achieve its sales of one trillion won in 2010 with net income of 80 billion won, in line with shareholder-frien...
